322 related articles for article (PubMed ID: 19700653)
1. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
[TBL] [Abstract][Full Text] [Related]
2. [Application of fecal DNA methylation biomarkers detection in gastric cancer screening].
Guo P; Zhou XJ; Xu L; Chen H; Zhao L; Sun MH; Hu H
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):808-812. PubMed ID: 33765723
[No Abstract] [Full Text] [Related]
3. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
Wang DR; Tang D
World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
6.
Liu L; Liu C; Fotouhi O; Fan Y; Wang K; Xia C; Shi B; Zhang G; Wang K; Kong F; Larsson C; Hu S; Xu D
Oncologist; 2017 Oct; 22(10):1178-1188. PubMed ID: 28754720
[TBL] [Abstract][Full Text] [Related]
7. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
8. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
9. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
[TBL] [Abstract][Full Text] [Related]
10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
11. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
Huang ZH; Li LH; Yang F; Wang JF
World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a prototype reverse hybridization assay and MethyLight for detection of SFRP2 promotor methylation in fecal DNA.
Kriegshäuser G; Enko D; Zitt M; Oberwalder M; Oberkanins C; Öfner D; Zeillinger R; Maximilian Müller H
Int J Biol Markers; 2017 Oct; 32(4):e467-e470. PubMed ID: 28777432
[TBL] [Abstract][Full Text] [Related]
13. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
[TBL] [Abstract][Full Text] [Related]
15. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
17. [Value of combined detection of ITGA4 and SFRP2 gene methylation in stool DNA in diagnosis and prognostic evaluation of colorectal tumors].
Jin H; Pang L; Li H; Xu M; Yan H; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):891-897. PubMed ID: 34238742
[TBL] [Abstract][Full Text] [Related]
18. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
[TBL] [Abstract][Full Text] [Related]
19. MGMT promoter methylation and field defect in sporadic colorectal cancer.
Shen L; Kondo Y; Rosner GL; Xiao L; Hernandez NS; Vilaythong J; Houlihan PS; Krouse RS; Prasad AR; Einspahr JG; Buckmeier J; Alberts DS; Hamilton SR; Issa JP
J Natl Cancer Inst; 2005 Sep; 97(18):1330-8. PubMed ID: 16174854
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
